![PDF) The use of Lactobacillus casei DG® prevents symptomatic episodes and reduces the antibiotic use in patients affected by chronic bacterial prostatitis: results from a phase IV study PDF) The use of Lactobacillus casei DG® prevents symptomatic episodes and reduces the antibiotic use in patients affected by chronic bacterial prostatitis: results from a phase IV study](https://i1.rgstatic.net/publication/348446334_The_use_of_Lactobacillus_casei_DGR_prevents_symptomatic_episodes_and_reduces_the_antibiotic_use_in_patients_affected_by_chronic_bacterial_prostatitis_results_from_a_phase_IV_study/links/5fffdc3992851c13fe0d7e21/largepreview.png)
PDF) The use of Lactobacillus casei DG® prevents symptomatic episodes and reduces the antibiotic use in patients affected by chronic bacterial prostatitis: results from a phase IV study
![In vitro and in vivo evidences for innate immune stimulators lactic acid bacterial starters isolated from fermented camel dairy products | Scientific Reports In vitro and in vivo evidences for innate immune stimulators lactic acid bacterial starters isolated from fermented camel dairy products | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41598-018-31006-3/MediaObjects/41598_2018_31006_Fig1_HTML.png)
In vitro and in vivo evidences for innate immune stimulators lactic acid bacterial starters isolated from fermented camel dairy products | Scientific Reports
![Frontiers | Quantitative Recovery of Viable Lactobacillus paracasei CNCM I-1572 (L. casei DG®) After Gastrointestinal Passage in Healthy Adults Frontiers | Quantitative Recovery of Viable Lactobacillus paracasei CNCM I-1572 (L. casei DG®) After Gastrointestinal Passage in Healthy Adults](https://www.frontiersin.org/files/Articles/372902/fmicb-09-01720-HTML/image_m/fmicb-09-01720-t001.jpg)
Frontiers | Quantitative Recovery of Viable Lactobacillus paracasei CNCM I-1572 (L. casei DG®) After Gastrointestinal Passage in Healthy Adults
![PDF) Survival of L. casei DG® (Lactobacillus paracasei CNCMI1572) in the gastrointestinal tract of a healthy paediatric population PDF) Survival of L. casei DG® (Lactobacillus paracasei CNCMI1572) in the gastrointestinal tract of a healthy paediatric population](https://i1.rgstatic.net/publication/329278496_Survival_of_L_casei_DGR_Lactobacillus_paracasei_CNCMI1572_in_the_gastrointestinal_tract_of_a_healthy_paediatric_population/links/5fb7ca1092851c933f432f48/largepreview.png)
PDF) Survival of L. casei DG® (Lactobacillus paracasei CNCMI1572) in the gastrointestinal tract of a healthy paediatric population
![PDF) Bacterial stimuli activate nitric oxide colonic mucosal production in diverticular disease. Protective effects of L. casei DG ® ( Lactobacillus paracasei CNCM I-1572) PDF) Bacterial stimuli activate nitric oxide colonic mucosal production in diverticular disease. Protective effects of L. casei DG ® ( Lactobacillus paracasei CNCM I-1572)](https://i1.rgstatic.net/publication/312235335_Bacterial_stimuli_activate_nitric_oxide_colonic_mucosal_production_in_diverticular_disease_Protective_effects_of_L_casei_DG_R_Lactobacillus_paracasei_CNCM_I-1572/links/5a33a19da6fdcc9b2d78857d/largepreview.png)
PDF) Bacterial stimuli activate nitric oxide colonic mucosal production in diverticular disease. Protective effects of L. casei DG ® ( Lactobacillus paracasei CNCM I-1572)
![Lactobacillus casei DG and its postbiotic reduce the inflammatory mucosal response: an ex-vivo organ culture model of post-infectious irritable bowel syndrome | BMC Gastroenterology | Full Text Lactobacillus casei DG and its postbiotic reduce the inflammatory mucosal response: an ex-vivo organ culture model of post-infectious irritable bowel syndrome | BMC Gastroenterology | Full Text](https://media.springernature.com/m685/springer-static/image/art%3A10.1186%2Fs12876-017-0605-x/MediaObjects/12876_2017_605_Fig3_HTML.gif)
Lactobacillus casei DG and its postbiotic reduce the inflammatory mucosal response: an ex-vivo organ culture model of post-infectious irritable bowel syndrome | BMC Gastroenterology | Full Text
![Inverigo, Italy - September 10, 2016: SOFAR ENTEROLACTIS Drinkable Lactobacillus Casei Nutritional Supplement In A Disposable Bottle Stock Photo, Picture and Royalty Free Image. Image 62870709. Inverigo, Italy - September 10, 2016: SOFAR ENTEROLACTIS Drinkable Lactobacillus Casei Nutritional Supplement In A Disposable Bottle Stock Photo, Picture and Royalty Free Image. Image 62870709.](https://previews.123rf.com/images/divgradcurl/divgradcurl1609/divgradcurl160900005/62870709-inverigo-italy-september-10-2016-sofar-enterolactis-drinkable-lactobacillus-casei-nutritional.jpg)
Inverigo, Italy - September 10, 2016: SOFAR ENTEROLACTIS Drinkable Lactobacillus Casei Nutritional Supplement In A Disposable Bottle Stock Photo, Picture and Royalty Free Image. Image 62870709.
![Effect of Lactobacillus paracasei CNCM I-1572 on symptoms, gut microbiota, short chain fatty acids, and immune activation in patients with irritable bowel syndrome: A pilot randomized clinical trial - Cesare Cremon, Simone Effect of Lactobacillus paracasei CNCM I-1572 on symptoms, gut microbiota, short chain fatty acids, and immune activation in patients with irritable bowel syndrome: A pilot randomized clinical trial - Cesare Cremon, Simone](https://journals.sagepub.com/cms/10.1177/2050640617736478/asset/images/large/10.1177_2050640617736478-fig1.jpeg)
Effect of Lactobacillus paracasei CNCM I-1572 on symptoms, gut microbiota, short chain fatty acids, and immune activation in patients with irritable bowel syndrome: A pilot randomized clinical trial - Cesare Cremon, Simone
![Lactobacillus casei DG and its postbiotic reduce the inflammatory mucosal response: an ex-vivo organ culture model of post-infectious irritable bowel syndrome | BMC Gastroenterology | Full Text Lactobacillus casei DG and its postbiotic reduce the inflammatory mucosal response: an ex-vivo organ culture model of post-infectious irritable bowel syndrome | BMC Gastroenterology | Full Text](https://media.springernature.com/m685/springer-static/image/art%3A10.1186%2Fs12876-017-0605-x/MediaObjects/12876_2017_605_Fig1_HTML.gif)
Lactobacillus casei DG and its postbiotic reduce the inflammatory mucosal response: an ex-vivo organ culture model of post-infectious irritable bowel syndrome | BMC Gastroenterology | Full Text
Comparative sequence analysis of a recA gene fragment brings new evidence for a change in the taxonomy of the Lactobacillus case
![Rectal Administration of Lactobacillus casei DG Modifies Flora Composition and Toll-Like Receptor Expression in Colonic Mucosa of Patients with Mild Ulcerative Colitis | Digestive Diseases and Sciences Rectal Administration of Lactobacillus casei DG Modifies Flora Composition and Toll-Like Receptor Expression in Colonic Mucosa of Patients with Mild Ulcerative Colitis | Digestive Diseases and Sciences](https://media.springernature.com/m685/springer-static/image/art%3A10.1007%2Fs10620-010-1384-1/MediaObjects/10620_2010_1384_Fig2_HTML.gif)
Rectal Administration of Lactobacillus casei DG Modifies Flora Composition and Toll-Like Receptor Expression in Colonic Mucosa of Patients with Mild Ulcerative Colitis | Digestive Diseases and Sciences
![Frontiers | The vaginal isolate Lactobacillus paracasei LPC-S01 (DSM 26760) is suitable for oral administration Frontiers | The vaginal isolate Lactobacillus paracasei LPC-S01 (DSM 26760) is suitable for oral administration](https://www.frontiersin.org/files/Articles/150035/fmicb-06-00952-HTML/image_m/fmicb-06-00952-g005.jpg)
Frontiers | The vaginal isolate Lactobacillus paracasei LPC-S01 (DSM 26760) is suitable for oral administration
SOFAR - ENTEROLACTIS® is the best ally to promote the balance of intestinal flora. The products in the range are mainly formulated with L. casei DG®, an exclusive probiotic strain, created and
![Frontiers | Quantitative Recovery of Viable Lactobacillus paracasei CNCM I-1572 (L. casei DG®) After Gastrointestinal Passage in Healthy Adults Frontiers | Quantitative Recovery of Viable Lactobacillus paracasei CNCM I-1572 (L. casei DG®) After Gastrointestinal Passage in Healthy Adults](https://www.frontiersin.org/files/Articles/372902/fmicb-09-01720-HTML/image_m/fmicb-09-01720-g003.jpg)
Frontiers | Quantitative Recovery of Viable Lactobacillus paracasei CNCM I-1572 (L. casei DG®) After Gastrointestinal Passage in Healthy Adults
![Survival of L. casei DG® (Lactobacillus paracasei CNCMI1572) in the gastrointestinal tract of a healthy paediatric population | European Journal of Nutrition Survival of L. casei DG® (Lactobacillus paracasei CNCMI1572) in the gastrointestinal tract of a healthy paediatric population | European Journal of Nutrition](https://media.springernature.com/m685/springer-static/image/art%3A10.1007%2Fs00394-018-1860-5/MediaObjects/394_2018_1860_Fig2_HTML.png)
Survival of L. casei DG® (Lactobacillus paracasei CNCMI1572) in the gastrointestinal tract of a healthy paediatric population | European Journal of Nutrition
![JCM | Free Full-Text | Lactobacillus paracasei CNCM I 1572: A Promising Candidate for Management of Colonic Diverticular Disease JCM | Free Full-Text | Lactobacillus paracasei CNCM I 1572: A Promising Candidate for Management of Colonic Diverticular Disease](https://pub.mdpi-res.com/jcm/jcm-11-01916/article_deploy/html/images/jcm-11-01916-g004.png?1648626041)
JCM | Free Full-Text | Lactobacillus paracasei CNCM I 1572: A Promising Candidate for Management of Colonic Diverticular Disease
![Frontiers | Quantitative Recovery of Viable Lactobacillus paracasei CNCM I-1572 (L. casei DG®) After Gastrointestinal Passage in Healthy Adults Frontiers | Quantitative Recovery of Viable Lactobacillus paracasei CNCM I-1572 (L. casei DG®) After Gastrointestinal Passage in Healthy Adults](https://www.frontiersin.org/files/Articles/372902/fmicb-09-01720-HTML/image_m/fmicb-09-01720-g002.jpg)
Frontiers | Quantitative Recovery of Viable Lactobacillus paracasei CNCM I-1572 (L. casei DG®) After Gastrointestinal Passage in Healthy Adults
![Effect of Lactobacillus paracasei CNCM I‐1572 on symptoms, gut microbiota, short chain fatty acids, and immune activation in patients with irritable bowel syndrome: A pilot randomized clinical trial - Cremon - 2018 - Effect of Lactobacillus paracasei CNCM I‐1572 on symptoms, gut microbiota, short chain fatty acids, and immune activation in patients with irritable bowel syndrome: A pilot randomized clinical trial - Cremon - 2018 -](https://onlinelibrary.wiley.com/cms/asset/5206294d-fb3e-47a6-b0f3-e7949d80b0f3/ueg2bf00173-fig-0002-m.jpg)
Effect of Lactobacillus paracasei CNCM I‐1572 on symptoms, gut microbiota, short chain fatty acids, and immune activation in patients with irritable bowel syndrome: A pilot randomized clinical trial - Cremon - 2018 -
![So Far Nahrungsergänzungsmittel Enterolactis Baby Tropfen, 8 ml, 8 ml, 1 : Amazon.de: Health & Personal Care So Far Nahrungsergänzungsmittel Enterolactis Baby Tropfen, 8 ml, 8 ml, 1 : Amazon.de: Health & Personal Care](https://m.media-amazon.com/images/I/61wVH0S2udL._AC_UF894,1000_QL80_.jpg)
So Far Nahrungsergänzungsmittel Enterolactis Baby Tropfen, 8 ml, 8 ml, 1 : Amazon.de: Health & Personal Care
![The use of Lactobacillus casei DG® prevents symptomatic episodes and reduces the antibiotic use in patients affected by chronic bacterial prostatitis: results from a phase IV study | World Journal of Urology The use of Lactobacillus casei DG® prevents symptomatic episodes and reduces the antibiotic use in patients affected by chronic bacterial prostatitis: results from a phase IV study | World Journal of Urology](https://media.springernature.com/m685/springer-static/image/art%3A10.1007%2Fs00345-020-03580-7/MediaObjects/345_2020_3580_Fig1_HTML.png)
The use of Lactobacillus casei DG® prevents symptomatic episodes and reduces the antibiotic use in patients affected by chronic bacterial prostatitis: results from a phase IV study | World Journal of Urology
![Foods | Free Full-Text | Health-Promoting Properties of Lacticaseibacillus paracasei: A Focus on Kefir Isolates and Exopolysaccharide-Producing Strains Foods | Free Full-Text | Health-Promoting Properties of Lacticaseibacillus paracasei: A Focus on Kefir Isolates and Exopolysaccharide-Producing Strains](https://pub.mdpi-res.com/foods/foods-10-02239/article_deploy/html/images/foods-10-02239-g001.png?1632272477)
Foods | Free Full-Text | Health-Promoting Properties of Lacticaseibacillus paracasei: A Focus on Kefir Isolates and Exopolysaccharide-Producing Strains
![JCM | Free Full-Text | Lactobacillus paracasei CNCM I 1572: A Promising Candidate for Management of Colonic Diverticular Disease JCM | Free Full-Text | Lactobacillus paracasei CNCM I 1572: A Promising Candidate for Management of Colonic Diverticular Disease](https://www.mdpi.com/jcm/jcm-11-01916/article_deploy/html/images/jcm-11-01916-g001.png)
JCM | Free Full-Text | Lactobacillus paracasei CNCM I 1572: A Promising Candidate for Management of Colonic Diverticular Disease
![Lactobacillus casei extracellular vesicles stimulate EGFR pathway likely due to the presence of proteins P40 and P75 bound to their surface | Scientific Reports Lactobacillus casei extracellular vesicles stimulate EGFR pathway likely due to the presence of proteins P40 and P75 bound to their surface | Scientific Reports](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41598-020-75930-9/MediaObjects/41598_2020_75930_Fig2_HTML.png)
Lactobacillus casei extracellular vesicles stimulate EGFR pathway likely due to the presence of proteins P40 and P75 bound to their surface | Scientific Reports
![JCM | Free Full-Text | Lactobacillus paracasei CNCM I 1572: A Promising Candidate for Management of Colonic Diverticular Disease JCM | Free Full-Text | Lactobacillus paracasei CNCM I 1572: A Promising Candidate for Management of Colonic Diverticular Disease](https://www.mdpi.com/jcm/jcm-11-01916/article_deploy/html/images/jcm-11-01916-g003.png)
JCM | Free Full-Text | Lactobacillus paracasei CNCM I 1572: A Promising Candidate for Management of Colonic Diverticular Disease
![The Lactobacillus Casei Group: Exploitation for Food and Health-Related Applications | Frontiers Research Topic The Lactobacillus Casei Group: Exploitation for Food and Health-Related Applications | Frontiers Research Topic](https://www.frontiersin.org/files/MyHome%20Article%20Library/343048/343048_Thumb_400.jpg)
The Lactobacillus Casei Group: Exploitation for Food and Health-Related Applications | Frontiers Research Topic
![PDF) Randomised clinical trial: Mesalazine and/or probiotics in maintaining remission of symptomatic uncomplicated diverticular disease - A double-blind, randomised, placebo-controlled study PDF) Randomised clinical trial: Mesalazine and/or probiotics in maintaining remission of symptomatic uncomplicated diverticular disease - A double-blind, randomised, placebo-controlled study](https://i1.rgstatic.net/publication/255984760_Randomised_clinical_trial_Mesalazine_andor_probiotics_in_maintaining_remission_of_symptomatic_uncomplicated_diverticular_disease_-_A_double-blind_randomised_placebo-controlled_study/links/5a7c8eae458515d353344fce/largepreview.png)
PDF) Randomised clinical trial: Mesalazine and/or probiotics in maintaining remission of symptomatic uncomplicated diverticular disease - A double-blind, randomised, placebo-controlled study
![Lactobacillus casei extracellular vesicles stimulate EGFR pathway likely due to the presence of proteins P40 and P75 bound to their surface | Scientific Reports Lactobacillus casei extracellular vesicles stimulate EGFR pathway likely due to the presence of proteins P40 and P75 bound to their surface | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41598-020-75930-9/MediaObjects/41598_2020_75930_Fig1_HTML.png)
Lactobacillus casei extracellular vesicles stimulate EGFR pathway likely due to the presence of proteins P40 and P75 bound to their surface | Scientific Reports
![A Novel Rhamnose-Rich Hetero-exopolysaccharide Isolated from Lactobacillus paracasei DG Activates THP-1 Human Monocytic Cells | Applied and Environmental Microbiology A Novel Rhamnose-Rich Hetero-exopolysaccharide Isolated from Lactobacillus paracasei DG Activates THP-1 Human Monocytic Cells | Applied and Environmental Microbiology](https://journals.asm.org/cms/10.1128/AEM.02702-16/asset/8c3ea820-dcae-481d-98d7-c97a81614bda/assets/graphic/zam9991176330001.jpeg)
A Novel Rhamnose-Rich Hetero-exopolysaccharide Isolated from Lactobacillus paracasei DG Activates THP-1 Human Monocytic Cells | Applied and Environmental Microbiology
![Lactobacillus casei extracellular vesicles stimulate EGFR pathway likely due to the presence of proteins P40 and P75 bound to their surface | Scientific Reports Lactobacillus casei extracellular vesicles stimulate EGFR pathway likely due to the presence of proteins P40 and P75 bound to their surface | Scientific Reports](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41598-020-75930-9/MediaObjects/41598_2020_75930_Fig3_HTML.png)
Lactobacillus casei extracellular vesicles stimulate EGFR pathway likely due to the presence of proteins P40 and P75 bound to their surface | Scientific Reports
![Survival of L. casei DG® (Lactobacillus paracasei CNCMI1572) in the gastrointestinal tract of a healthy paediatric population | European Journal of Nutrition Survival of L. casei DG® (Lactobacillus paracasei CNCMI1572) in the gastrointestinal tract of a healthy paediatric population | European Journal of Nutrition](https://media.springernature.com/m685/springer-static/image/art%3A10.1007%2Fs00394-018-1860-5/MediaObjects/394_2018_1860_Fig1_HTML.png)